Territorial Department of Nephrology and Dialysis, ASSL Cagliari, Cagliari, Italy; Department of Biology and Biotechnology, University of Pavia, Pavia, Italy.
Former Director of Territorial, Department of Nephrology and Dialysis, ASL Cagliari, Cagliari, Italy; Member of Italian Society of Nephrology, Cagliari, Italy.
J Ren Nutr. 2019 Mar;29(2):126-135. doi: 10.1053/j.jrn.2018.07.005. Epub 2018 Oct 16.
The objective of the study was to quantify the loss of total amino acids (TAAs), nonessential amino acids, essential amino acids, and branched chain amino acids (BCAAs) produced by high-efficiency hemodialysis (HEHD), postdilution hemodiafiltration (HDFpost), and predilution hemodiafiltration (HDFpre) using high ultrafiltration volumes; and to define the specific AA losses registered in HEHD, HDFpost, and HDFpre; to identify a potential metabolic and nutritional decline into protein energy wasting; to compare AA analysis of arterial blood samples taken from healthy controls and patients with end-stage renal disease undergoing hemodialysis.
Identical dialysis monitors, membranes, and dialysate/infusate were used to homogenize extracorporeal body influence. Ten patients were recruited and randomized to receive treatment with HEHD, HDFpost, and HDFpre it was used on-line dialytic water methodologies (OL); patients' AA arterial concentrations were measured at the start and on completion of dialysis; TAA from the dialyzer filter was calculated, and baseline levels were subsequently compared with findings obtained 1 year later. Finally, the results obtained were compared with the data from a study of 8 healthy volunteers conducted using bioimpedance analysis and laboratory blood tests to assess nutritional status.
A higher convective dose results in a higher weekly loss of TAA, nonessential AAs, essential AAs, and BCAAs (HEHD: 15.7 g; HDFpost-OL: 16.1 g; HDFpre-OL: 16.3 g, P < .01). After 12 months, the same hemodialys patients showed a reduced body and water intracellular mass and reduced phase angle. Arterial concentrations of TAAs and BCAAs were lower than those detected in healthy subjects (P < .01).
The study shows that the AA losses in dialytic liquid are greater after high exchange volume HDF techniques, especially HDFpre. The AA losses are not metabolically compensated, so these increase the derangements of predialytic arterial plasma AA levels. Both AA losses and arterial AA perturbations further worsened body composition already after 12 months of additional dialysis.
本研究旨在量化高效血液透析(HEHD)、后稀释血液透析滤过(HDFpost)和预稀释血液透析滤过(HDFpre)在使用高超滤量时产生的总氨基酸(TAAs)、非必需氨基酸、必需氨基酸和支链氨基酸(BCAAs)的损失,并确定 HEHD、HDFpost 和 HDFpre 中登记的特定氨基酸损失;确定潜在的代谢和营养下降到蛋白质能量消耗;比较从健康对照者和接受血液透析的终末期肾病患者采集的动脉血样本的氨基酸分析。
使用相同的透析监测器、膜和透析液/输液来均匀化体外身体影响。招募了 10 名患者,并随机分配接受 HEHD、HDFpost 和 HDFpre 治疗,使用在线透析水方法(OL);在透析开始和结束时测量患者的动脉氨基酸浓度;从透析器过滤器计算 TAA,并随后将基线水平与 1 年后的结果进行比较。最后,将结果与 8 名健康志愿者的生物阻抗分析和实验室血液检查研究数据进行比较,以评估营养状况。
更高的对流剂量导致更高的每周 TAAs、非必需氨基酸、必需氨基酸和 BCAAs 损失(HEHD:15.7g;HDFpost-OL:16.1g;HDFpre-OL:16.3g,P<.01)。12 个月后,相同的血液透析患者显示身体和水细胞内质量减少,相位角降低。TAA 和 BCAAs 的动脉浓度低于健康受试者(P<.01)。
研究表明,高交换量 HDF 技术后,尤其是 HDFpre,透析液中的氨基酸损失更大。氨基酸损失没有被代谢补偿,因此这些会增加透析前动脉血浆氨基酸水平的紊乱。AA 损失和动脉 AA 扰动在额外透析 12 个月后进一步恶化了身体成分。